Exosome RNA Exosome RNA Research & Industry News
Woolsey Pharmaceuticals announced extended Series B financing to advance BRAVYL® for ALS. Research shows extracellular vesicles play a role in TDP-43 pathology, with BRAVYL significantly reducing aggregation and cytoplasmic redistribution, offering a potential breakthrough in ALS treatment...
Read More »Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program
